Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cochrane Database of Systematic Reviews is Scopus-indexed (Q1, CiteScore 10.2), WoS SCIE. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 1361-6137Verify ISSN ↗1469-493XVerify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: About US$5,100 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 22 / 278 | 92nd | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1998–present, best quartile Q1, CiteScore 10.2.
Cochrane Database of Systematic Reviews is Q1 in Pharmacology (medical) (rank 22 of 278), by CiteScore 2025.
Cochrane Database of Systematic Reviews is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.2, which places it in quartile Q1 at the 92nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.670, quartile Q1, with an H-index of 359.
The publisher lists an article processing charge of about US$5,100 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cochrane Database of Systematic Reviews is published by John Wiley and Sons Ltd. Its print ISSN is 1361-6137 and its online ISSN is 1469-493X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cochrane Database of Systematic Reviews has an h-index of 461 and a 2-year mean of 7.29 citations per paper (OpenAlex). Its Scopus CiteScore is 10.2, quartile Q1. On 2-year citations it ranks #11 of 271 Scopus journals in Pharmacology (medical).
Cochrane Database of Systematic Reviews published 429 papers in 2025; its busiest recent year was 2017 with 1,363. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from United Kingdom (21%), United States (10.4%) and Australia (9.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 807 retracted papers are recorded (28.4 per 1,000 papers). The Problematic Paper Screener flags 23 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.